Kezar Life Cost Of Revenue Over Time

KZR Stock  USD 6.55  0.20  2.96%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Kezar Life Performance and Kezar Life Correlation.
  
As of 12/16/2024, Cost Of Revenue is likely to drop to about 886 K.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kezar Life. If investors know Kezar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kezar Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(13.12)
Revenue Per Share
0.962
Return On Assets
(0.28)
Return On Equity
(0.51)
The market value of Kezar Life Sciences is measured differently than its book value, which is the value of Kezar that is recorded on the company's balance sheet. Investors also form their own opinion of Kezar Life's value that differs from its market value or its book value, called intrinsic value, which is Kezar Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kezar Life's market value can be influenced by many factors that don't directly affect Kezar Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kezar Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kezar Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kezar Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Cost Of Revenue Analysis

Compare Kezar Life Sciences and related stocks such as Century Therapeutics, Mineralys Therapeutics,, and Nkarta Inc Cost Of Revenue Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
201020112012201320142015201620172018201920202021202220232024
IPSC888.8 M888.8 M888.8 M888.8 M888.8 M888.8 M467.8 M249 K249 K249 K1.8 M4.6 M10.1 M13 M12.4 M
NKTX17.2 K17.2 K17.2 K17.2 K17.2 K17.2 K17.2 K17.2 K17.2 K17.2 KM2.1 M6.6 M5.9 M3.4 M
SRZN2.9 M2.9 M2.9 M2.9 M2.9 M2.9 M2.9 M2.9 M2.9 M2.9 M2.9 M3.3 M3.3 M27.2 M28.6 M
BOLT26 M26 M26 M26 M26 M26 M26 M26 M26 M26 M40.4 M3.7 M4.9 M1.9 M1.8 M
LRMR70 K70 K70 K70 K70 K70 K212 K188 K261 K78 K155 K326 K272 K311 K228.9 K
KROS10.1 M10.1 M10.1 M10.1 M10.1 M10.1 M10.1 M10.1 M10.1 M17.3 M605 K898 K1.6 M815 K774.2 K
LYEL7.5 M7.5 M7.5 M7.5 M7.5 M7.5 M7.5 M7.5 M7.5 M7.5 M7.5 M14.5 M16.5 M20.2 M16.1 M
CGEM0.00.00.00.00.00.00.070 K70 K70 K62 K53 K93 K310 K325.5 K
GLUE72 K72 K72 K72 K72 K72 K72 K72 K72 K72 K537 K2.1 M8.6 M6.2 M3.9 M
RVMD26.6 M26.6 M26.6 M26.6 M26.6 M26.6 M26.6 M26.6 M50.3 M91.8 M132.3 M7.3 M9.7 M411.2 M431.8 M
STTK29 M29 M29 M29 M29 M29 M29 M29 M29 M29 M37.5 M1.4 M3.4 MM3.8 M
KYMR825 K825 K825 K825 K825 K825 K825 K825 K825 K825 K62.1 M2.4 MM189.1 M198.5 M
NRIX45 M45 M45 M45 M45 M45 M45 M45 M45 M66.5 M6.1 M10.8 M189.1 M217.5 M228.4 M
HOWL463 K463 K463 K463 K463 K463 K463 K463 K463 K463 K777 K735 K2.5 M38.9 M40.9 M
IKNA24.9 M24.9 M24.9 M24.9 M24.9 M24.9 M24.9 M24.9 M24.9 M24.9 M44.8 M47.1 MMM969 K
STOK0.00.00.00.00.00.00.00.00.0450 K1.9 M2.2 M3.5 M4.7 MM

Kezar Life Sciences and related stocks such as Century Therapeutics, Mineralys Therapeutics,, and Nkarta Inc Cost Of Revenue description

Cost of Revenue is found on Kezar Life Sciences income statement and represents the costs associated with goods and services Kezar Life provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

My Equities

My Current Equities and Potential Positions

Kezar Life Sciences
KZR
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
LocationCalifornia; U.S.A
ExchangeNASDAQ Exchange
USD 6.55

Additional Tools for Kezar Stock Analysis

When running Kezar Life's price analysis, check to measure Kezar Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kezar Life is operating at the current time. Most of Kezar Life's value examination focuses on studying past and present price action to predict the probability of Kezar Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kezar Life's price. Additionally, you may evaluate how the addition of Kezar Life to your portfolios can decrease your overall portfolio volatility.